Spirig HealthCare AG - Sitagliptin Metformin Spirig HC 50/500 mg, Filmtabletten | | 68396 | | 01 | | Sitagliptin Metformin Spirig HC 50/500 mg | | Filmtabletten | | A10BD07 | | Metformine et Sitagliptine | | 18.05.2022 | | |
| Composition | sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 500 mg, cellulosum microcristallinum, povidonum K 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), E 171, macrogolum, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 1.03 mg. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Metformine Hydrochloride | 500 mg | Sitagliptine | 50 mg |
| BAG: Principe actif | Concentr. |
---|
Metformine Hydrochloride | 500 mg | Sitagliptine | 50 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Rubrum) | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Macrogol | | | Natrii Laurilsulfas | | | Natrii Stearylis Fumaras | | | Poly(Alcohol Vinylicus) | | Überzug | Povidonum K | 29-32 | | Pro Compresso Obducto | | | Talcum | | |
| |
| |
|